Great News! | Maxin’s Fully Automated Immunohistochemistry Stainer Secures Class I Medical Device Production Filing Certificate!

Posted by

6 2 月, 2026

On 6 2 月, 2026

Introduction:

As early as 2016, the State Council issued the “13th Five-Year National Science and Technology Innovation Plan” (State Council Document [2016] No. 43), which clearly outlined the focus on localization in the in vitro diagnostic product sector, specifically mentioning the development of major products such as rapid pathological diagnosis systems,to enhance the competitiveness of China’s in vitro diagnostic industry.

In recent years, national and provincial-level authorities have repeatedly issued documents and formulated a series of measures to encourage the localization of medical devices, throughcore technology research and development, breaking foreign monopolies, and gradually changing the industry’s situation of being constrained by others with“domesticsubstitution”Form.

On May 19, Maxin’s fully automatic immunohistochemical staining instrument (Titan S) joyfully received the Class I Medical Device Filing Certificate (Filing No.: Min Rong Device Bei 20210024) issued by the Fuzhou Market Supervision and Administration Bureau, marking a particularly crucial step for Maxin on the path of practicing domestic substitution in in vitro diagnostics.

About Titan S

Titan S is a new generation fully automatic pathological staining system independently developed by Maxin. Since its launch,with its excellent product performance, highly intelligent and convenient operation, and stable and reliable staining results, it has been highly favored by pathology colleagues. It has repeatedly appeared on international stages, showcasing the style of domestic pathological innovation products, and in 2019,it won the “Innovation Star” Cup Outstanding Innovative Product in In Vitro Diagnostics—Instrument Award.

Titan S Core Advantages

High system sensitivity
Broad primary antibody compatibility
Stable results
Powerful functionality
High cost-effectiveness
Simple operation
After-sales support

Bearing the Mission

The localization of Titan S is another fruitful achievement for Maxin in responding to national policy calls, deepening industrial layout, and accelerating the process of “domestic substitution”. It is alsoScientific research and innovationTEXT_28, meeting users’ personalized needs (domestic/imported), enriching its own product line, comprehensively enhancing market competitiveness, and promoting the healthy development of the in vitro diagnostic industry.

As a domestic national enterprise, Maxin carries glory and responsibility,Weand will be committed to innovation, fully promoting the localization process of products such as pathological diagnostic reagents and automated instruments, providing comprehensive and higher-quality pathological diagnostic products and services for pathology workers in China and globally.

发表回复 取消回复

发表回复取消回复